Welcome to our dedicated page for Tenon Medical SEC filings (Ticker: TNONW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Tenon Medical, Inc. (TNONW), a medical device company focused on a minimally invasive sacroiliac (SI) joint implant approach. The company’s filings, such as Forms 8-K, describe material events, corporate governance actions, and details about its capital structure, including warrants and equity incentive plans.
Tenon Medical, Inc.’s SEC filings include disclosures about its 2025 Annual Meeting of Stockholders, where stockholders voted on the election of directors, the exercisability of Series C-1 and Series C-2 Warrants, amendments to the 2022 Equity Incentive Plan, and ratification of the company’s independent auditor. These documents explain how the company manages equity-based compensation, share reserves, and warrant terms that may affect holders of its securities, including warrants trading under the symbol TNONW on The Nasdaq Stock Market LLC.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q (when filed), users can review discussions of Tenon Medical’s medical device business, risk factors, and financial statements. Current reports on Form 8-K highlight specific events such as stockholder meetings, changes to equity plans, and other significant developments. For investors tracking ownership changes, insider transaction reports on Form 4, when available, provide details on purchases, sales, or grants involving the company’s equity securities.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, such as warrant terms, equity plan amendments, and voting results. Real-time updates from the SEC’s EDGAR system help users see new filings as they appear, while AI explanations make complex regulatory language more accessible for readers analyzing Tenon Medical, Inc.’s disclosures.
Tenon Medical, Inc. filed an 8-K dated September 23, 2025 that lists its publicly traded securities and records signatures and share-count figures for several named officers and directors. The document references Common Stock (par value $0.001) trading under the symbol TNON and Warrants trading under TNONW on The Nasdaq Stock Market. Individual entries show numeric holdings for Steven Foster, Richard Ginn, Stephen Hochschuler, MD, Ivan Howard, Kristine Jacques, and Robert Weigle, and the filing is executed by Steven M. Foster in his capacity as Chief Executive Officer and President.
FAQ
What is the current stock price of Tenon Medical (TNONW)?
